Table 1.
Baseline characteristics of the selected cohort.
Fig 1.
Prescription-Level Distribution of Drug–Drug Interaction Categories.
Table 2.
Top Drug-Drug Interactions by Severity and Frequency.
Fig 2.
Network of High-Frequency Drug–Drug Interactions with Severity Coding.
Table 3.
Distribution and Severity of Drug–Drug Interactions Stratified by Sex and Age Group.
Table 4.
Prescription Volume, Polypharmacy, and Severity-Profiled Drug–Drug Interactions Across the Ten Highest-Volume Physician Specialties.
Fig 3.
Multivariable linear regression for predictors of the number of DDIs in prescriptions.
Fig 4.
Interaction-Adjusted Effects of Predictors on Drug–Drug Interaction Counts.
Fig 5.
Estimated Effects of Predictors on the Likelihood of Contraindicated Drug–Drug Interactions.